$2975 | SAVE $525 | Single User
$5950 | SAVE $1,050 | Site License
$8925 | SAVE $1,575 | Enterprise License

G Protein Coupled Bile Acid Receptor 1 - Pipeline Review, H2 2019
[Published by Global Markets Direct]

Published by Global Markets Direct: 30 Aug 2019 | 236574 | In Stock
Related Topics: Dermatitis , Dermatology , Diabetes , Eczema , Obesity , Protein , Ulcerative Colitis

Introduction

G Protein Coupled Bile Acid Receptor 1 - Pipeline Review, H2 2019

Summary

According to the recently published report 'G Protein Coupled Bile Acid Receptor 1 - Pipeline Review, H2 2019'; G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes.

G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - G protein-coupled bile acid receptor 1 (GPBAR1) is a protein encoded by the GPBAR1 gene. It is a receptor for bile acid. Bile acid-binding induces its internalization, activation of extracellular signal-regulated kinase and intracellular cAMP production. It is involved in the suppression of macrophage functions by bile acids.

The report 'G Protein Coupled Bile Acid Receptor 1 - Pipeline Review, H2 2019' outlays comprehensive information on the G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II and Preclinical stages are 1 and 4 respectively. Similarly, the universities portfolio in Preclinical stages comprises 2 molecules, respectively. Report covers products from therapy areas Metabolic Disorders, Dermatology, Gastrointestinal and Undisclosed which include indications Type 2 Diabetes, Atopic Dermatitis (Atopic Eczema), Metabolic Syndrome, Obesity, Ulcerative Colitis and Unspecified.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape for G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1)

- The report reviews G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) targeted therapeutics and enlists all their major and minor projects

- The report assesses G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news and deals related to G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand the targeted therapy areas and indications for G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1)

- Identify the use of drugs for target identification and drug repurposing

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) development landscape

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
for G Protein Coupled Bile Acid Receptor 1 - Pipeline Review, H2 2019 [Published by Global Markets Direct]

  • Table of Contents

    List of Tables

    List of Figures

    Introduction

    Global Markets Direct Report Coverage

    G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Overview

    G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Therapeutics Development

    Products under Development by Stage of Development

    Products under Development by Therapy Area

    Products under Development by Indication

    Products under Development by Companies

    Products under Development by Universities/Institutes

    G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Therapeutics Assessment

    Assessment by Mechanism of Action

    Assessment by Route of Administration

    Assessment by Molecule Type

    G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Companies Involved in Therapeutics Development

    Ardelyx Inc

    Cadila Healthcare Ltd

    G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Drug Profiles

    Drug to Agonize GPBAR1 for Type 2 Diabetes and Metabolic Syndrome - Drug Profile

    Product Description

    Mechanism Of Action

    R&D Progress

    HY-209 - Drug Profile

    Product Description

    Mechanism Of Action

    R&D Progress

    NuColin - Drug Profile

    Product Description

    Mechanism Of Action

    R&D Progress

    S-0071261 - Drug Profile

    Product Description

    Mechanism Of Action

    R&D Progress

    Small Molecule to Agonize TGR5 for Unspecified Indications - Drug Profile

    Product Description

    Mechanism Of Action

    R&D Progress

    Small Molecules to Agonize GPBAR1 for Type 2 Diabetes - Drug Profile

    Product Description

    Mechanism Of Action

    R&D Progress

    Small Molecules to Agonize TGR-5 Receptor for Type 2 Diabetes and Obesity - Drug Profile

    Product Description

    Mechanism Of Action

    R&D Progress

    G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Dormant Products

    G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Discontinued Products

    Appendix

    Methodology

    Coverage

    Secondary Research

    Primary Research

    Expert Panel Validation

    Contact Us

    Disclaimer

    Appendix

Additional Details

Publisher

Global Markets Direct

Publisher Information

Reference

236574 | GMDHC1940TDB

Number of Pages

29

Report Format

PDF

Global Markets Direct Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H2 2016
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H2 2...
26 Oct 2016 by Global Markets Direct USD $2,975 (normally
USD $3,500)
More Info
SAVE 15% today! Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2016
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or ...
26 Oct 2016 by Global Markets Direct USD $2,975 (normally
USD $3,500)
More Info
SAVE 15% today! Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) - Pipeline Review, H2 2016
Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 o...
26 Oct 2016 by Global Markets Direct USD $2,975 (normally
USD $3,500)
More Info
SAVE 15% today! Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review...
26 Oct 2016 by Global Markets Direct USD $2,975 (normally
USD $3,500)
More Info
SAVE 15% today! Protein Sciences Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryProtein Sciences Corporation (Protein Sciences) is a biotechnology company that develops and ...
12 May 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Protagen Protein Services GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryProtagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co. KG, ...
12 May 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Protein Sciences Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryProtein Sciences Corporation (Protein Sciences) is a biotechnology company that develops and ...
15 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Protagen Protein Services GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryProtagen Protein Services GmbH (PPS) is a contract research organization that focuses on prot...
15 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Electrophoresis Reagents Market by Product (Dyes (EtBr & SYBR) Gels (Polyacrylamide, Starch, & Agarose) Buffer (TBE & TAE)) by Application (Protein Analysis, DNA & RNA Analysis) by Technique (Gel & Capillary Electrophoresis) - Global Forecast to 2020
The global electrophoresis reagents market is expected to grow at a CAGR of 5.4% during the forecast...
15 Feb 2016 by MarketsandMarkets USD $3,953 (normally
USD $4,651)
More Info
SAVE 15% today! Protein Labeling Market by Product (Reagents, Kits, & Services), Labeling Method (In Vitro Labeling, In Vivo Labeling), Application (Cell-Based Assay, Fluorescence Microscopy, Immunological Technique), & Region - Global Forecast to 2020
The global protein labeling market is expected to reach USD 1,894.5 million by 2020 from USD 1,089.5...
04 Dec 2015 by MarketsandMarkets USD $3,953 (normally
USD $4,651)
More Info

This report is published by Global Markets Direct

Download Free Report Summary PDF

G Protein Coupled Bile Acid Receptor 1 - Pipeline Review, H2 2019 [Published by Global Markets Direct] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...